ArticleCancers2026

Characteristics and Clinical Outcomes of BRCA Germline Mutation Carriers with Advanced Breast Cancer Treated with PARP (Poly ADP-Ribose Polymerase) Inhibitors: A Single-Institution Experience.

Fatma Nihan Akkoc Mustafayev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.